Prostaglandin E2 as a therapeutic target in bladder cancer: From basic science to clinical trials
Benjamin L. Woolbright, Carol C. Pilbeam, John A. Taylor
Topics & Concepts
CardiotoxicityMedicineClinical trialProstaglandin E2ImmunosuppressionLipid signalingBladder cancerBasic scienceCancerCyclooxygenaseMediatorPharmacologyCancer researchOncologyInternal medicineInflammationChemotherapyBiologyEnzymeNeuroscienceBiochemistryInflammatory mediators and NSAID effectsEstrogen and related hormone effectsCancer, Stress, Anesthesia, and Immune Response